The METEX study: Methotrexate versus expectant management in women with ectopic pregnancy: A randomised controlled trial

BACKGROUND: Patients with ectopic pregnancy (EP) and low serum hCG concentrations and women with a pregnancy of unknown location (PUL) and plateauing serum hCG levels are commonly treated with systemic methotrexate (MTX). However, there is no evidence that treatment in these particular subgroups of...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: van Mello, Norah M, Mol, Femke, Adriaanse, Albert H, Boss, Erik A, Dijkman, Antonius B, Doornbos, Johannes PR, Emanuel, Mark Hans, Friederich, Jaap, Leeuw-Harmsen, Loes van der, Lips, Jos P, van Santbrink, Evert JP, Verhoeve, Harold R, Visser, Harry, Ankum, Willem M, Veen, Fulco van der, Mol, Ben W, Hajenius, Petra J
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2008
Témata:
Study Protocol
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2453103/
https://ncbi.nlm.nih.gov/pubmed/18565217
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6874-8-10
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky